Bénéfices
| Q1 2024 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.620 | ||
| Révision: | $2.48B | $2.14B | — |
| Q4 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.920 | 2.280 | 0.3600 |
| Révision: | $2.47B | $2.09B | -$157.00M |
| Q3 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.150 | 1.660 | 0.5100 |
| Révision: | $2.24B | $2.08B | $27.00M |
| Q2 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 0.740 | 1.210 | 0.4700 |
| Révision: | $2.19B | $1.97B | -$19.00M |
